2026 Call for Late-Breaking, Encore, and Trial in Progress Abstract Submissions: NOW OPEN!

The 2026 Call for 2026 Call for Late-Breaking, Encore, and Trial in Progress Abstract Submissions is now open! Don’t miss the opportunity to spotlight your latest research at the ASCPT 2026 Annual Meeting, taking place March 4-6, 2026, in Denver, CO. Accepted abstracts will be presented in person at the meeting and will be published Abstract Supplement to ASCPT’s Clinical Pharmacology & Therapeutics Journal.

All abstracts must be submitted through ASCPT’s online submission portal by the deadline of Thursday, November 6, 2025 at 4:00 pm Eastern.

View the Late-Breaking, Encore, and Trial in Progress Abstract Submission Guidelines for full submission details and criteria.

Submit Your Abstract

If you have questions about abstracts or the submission process, please email meetings@ascpt.org.

2026 Call for Abstract Submissions
The deadline for 2026 Regular Abstract Submissions has passed. Abstract submitters will be notified of acceptance decisions via email in mid-November 2025. Please contact meetings@ascpt.org with any questions.

2026 Call for Session Proposals
The deadline for the 2026 Call for Session Proposals has passed. Session proposal submitters will be notified of acceptance decisions in early September 2025. Please contact meetings@ascpt.org with any questions.

2026 Annual Meeting Deadlines
SCIENTIFIC AWARDS NOMINATIONS | THURSDAY, July 24, 2025, 4:00 PM ET
ABSTRACT SUBMISSION | FRIDAY , SEPTEMBER12, 2025, 4:00 PM ET
LATE-BREAKING, ENCORE, AND TRIALS IN PROGRESS ABSTRACT SUBMISSION | NOVEMBER 6, 2025, 4:00 PM